Yes it makes for great trading opportunities, but given I am not a trader it is not much use for me. I am long term fundementals-type investor.
The problem in the biotech field it is not very helpful to know about fundementals as the companies that have good fundementals tend to get ignored and run out of money while everyone rushes into the the latest hype-factory. I find it extremely frustrating.
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data, page-863
-
- There are more pages in this discussion • 176 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $7.664K | 403.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1202498 | 5 |
View Market Depth
| Last trade - 13.42pm 27/09/2024 (20 minute delay) ? |
| BIT (ASX) Chart |